調査レポートカテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

Global Stroke Diagnostics and Therapeutics Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

脳卒中の診断と治療の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2023）

◆タイトル：Global Stroke Diagnostics and Therapeutics Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
◆商品コード：GIR8106237
◆調査・発行会社：Global Info Research
◆発行日：2018年9月14日
◆ページ数：120
◆レポート形式：（印刷可能）PDF / 英語
◆納品方法：Eメール
◆調査対象地域：世界
◆産業分野：医療・バイオ
◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,480 ⇒換算￥375,840	見積依頼/購入/質問フォーム
Multi User（10名様閲覧用）	USD5,220 ⇒換算￥563,760	見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）	USD6,960 ⇒換算￥751,680	見積依頼/購入/質問フォーム

※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常2日～3日以内に納品致します。
※商品の納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。（振込先：三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobal Info Researchの日本における正規販売代理店です。

【レポートの概要】

本調査レポートは、脳卒中の診断と治療の世界市場について調べ、まとめました。種類別セグメントは、診断、治療学等、用途別セグメントは、虚血性脳卒中、出血性脳卒中等に区分しました。脳卒中の診断と治療の世界市場概観、メーカー動向、メーカー別脳卒中の診断と治療シェア、市場規模推移、市場規模予測、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。
・脳卒中の診断と治療の市場概観
・脳卒中の診断と治療のメーカー概要（事業概要、製品種類、価格、売上、市場シェア等）
・脳卒中の診断と治療のメーカー別販売動向、市場シェア、市場集中度、競争動向
・脳卒中の診断と治療の世界市場規模
・脳卒中の診断と治療の北米市場分析（アメリカ、カナダ、メキシコ等）
・脳卒中の診断と治療のアメリカ市場規模推移
・脳卒中の診断と治療のカナダ市場規模推移
・脳卒中の診断と治療のメキシコ市場規模推移
・脳卒中の診断と治療のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）
・脳卒中の診断と治療のドイツ市場規模推移
・脳卒中の診断と治療のイギリス市場規模推移
・脳卒中の診断と治療のロシア市場規模推移
・脳卒中の診断と治療のアジア市場分析（日本、中国、韓国、インド、東南アジア等）
・脳卒中の診断と治療の日本市場規模推移
・脳卒中の診断と治療の中国市場規模推移
・脳卒中の診断と治療の韓国市場規模推移
・脳卒中の診断と治療のインド市場規模推移
・脳卒中の診断と治療の東南アジア市場規模推移
・脳卒中の診断と治療の南米市場分析（ブラジル、アルゼンチン等）
・脳卒中の診断と治療の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等）
・脳卒中の診断と治療の種類別分析/市場規模推移（診断、治療学）
・脳卒中の診断と治療の用途別分析/市場規模推移（虚血性脳卒中、出血性脳卒中）
・脳卒中の診断と治療の市場予測（地域別予測、種類別予測、用途別予測）
・脳卒中の診断と治療の販売チャネル・代理店・貿易業者・ディーラー分析

Stroke refers to the brain attack. Stroke occurs when the supply of blood to the brain is either interrupted or reduced.

Scope of the Report:

This report focuses on the Stroke Diagnostics and Therapeutics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Increasing number of mergers and acquisitions, rapid product launches, and rise in number of collaborations and partnerships are some of the latest trends that have been observed in the global stroke diagnostics and therapeutics market.

The worldwide market for Stroke Diagnostics and Therapeutics is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

Abbott Laboratories

Cordis

Boston Scientific

Siemens

Genentech

Koninklijke Philips

Medtronic

GE Healthcare

Stryker

Merck

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Diagnostics

Therapeutics

Market Segment by Applications, can be divided into

Ischemic Stroke

Haemorrhagic Stroke

There are 15 Chapters to deeply display the global Stroke Diagnostics and Therapeutics market.

Chapter 1, to describe Stroke Diagnostics and Therapeutics Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Stroke Diagnostics and Therapeutics, with sales, revenue, and price of Stroke Diagnostics and Therapeutics, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Stroke Diagnostics and Therapeutics, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Stroke Diagnostics and Therapeutics market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Stroke Diagnostics and Therapeutics sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

【レポートの目次】

Table of Contents

1 Market Overview

1.1 Stroke Diagnostics and Therapeutics Introduction

1.2 Market Analysis by Type

1.2.1 Diagnostics

1.2.2 Therapeutics

1.3 Market Analysis by Applications

1.3.1 Ischemic Stroke

1.3.2 Haemorrhagic Stroke

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Abbott Laboratories

2.1.1 Business Overview

2.1.2 Stroke Diagnostics and Therapeutics Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Abbott Laboratories Stroke Diagnostics and Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Cordis

2.2.1 Business Overview

2.2.2 Stroke Diagnostics and Therapeutics Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Cordis Stroke Diagnostics and Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Boston Scientific

2.3.1 Business Overview

2.3.2 Stroke Diagnostics and Therapeutics Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Boston Scientific Stroke Diagnostics and Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Siemens

2.4.1 Business Overview

2.4.2 Stroke Diagnostics and Therapeutics Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Siemens Stroke Diagnostics and Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Genentech

2.5.1 Business Overview

2.5.2 Stroke Diagnostics and Therapeutics Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Genentech Stroke Diagnostics and Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Koninklijke Philips

2.6.1 Business Overview

2.6.2 Stroke Diagnostics and Therapeutics Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Koninklijke Philips Stroke Diagnostics and Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Medtronic

2.7.1 Business Overview

2.7.2 Stroke Diagnostics and Therapeutics Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Medtronic Stroke Diagnostics and Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 GE Healthcare

2.8.1 Business Overview

2.8.2 Stroke Diagnostics and Therapeutics Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 GE Healthcare Stroke Diagnostics and Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9 Stryker

2.9.1 Business Overview

2.9.2 Stroke Diagnostics and Therapeutics Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Stryker Stroke Diagnostics and Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.10 Merck

2.10.1 Business Overview

2.10.2 Stroke Diagnostics and Therapeutics Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Merck Stroke Diagnostics and Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Stroke Diagnostics and Therapeutics Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Stroke Diagnostics and Therapeutics Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Stroke Diagnostics and Therapeutics Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Stroke Diagnostics and Therapeutics Manufacturer Market Share in 2017

3.3.2 Top 6 Stroke Diagnostics and Therapeutics Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Stroke Diagnostics and Therapeutics Market Analysis by Regions

4.1 Global Stroke Diagnostics and Therapeutics Sales, Revenue and Market Share by Regions

4.1.1 Global Stroke Diagnostics and Therapeutics Sales and Market Share by Regions (2013-2018)

4.1.2 Global Stroke Diagnostics and Therapeutics Revenue and Market Share by Regions (2013-2018)

4.2 North America Stroke Diagnostics and Therapeutics Sales and Growth Rate (2013-2018)

4.3 Europe Stroke Diagnostics and Therapeutics Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Stroke Diagnostics and Therapeutics Sales and Growth Rate (2013-2018)

4.5 South America Stroke Diagnostics and Therapeutics Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Stroke Diagnostics and Therapeutics Sales and Growth Rate (2013-2018)

5 North America Stroke Diagnostics and Therapeutics by Countries

5.1 North America Stroke Diagnostics and Therapeutics Sales, Revenue and Market Share by Countries

5.1.1 North America Stroke Diagnostics and Therapeutics Sales and Market Share by Countries (2013-2018)

5.1.2 North America Stroke Diagnostics and Therapeutics Revenue and Market Share by Countries (2013-2018)

5.2 United States Stroke Diagnostics and Therapeutics Sales and Growth Rate (2013-2018)

5.3 Canada Stroke Diagnostics and Therapeutics Sales and Growth Rate (2013-2018)

5.4 Mexico Stroke Diagnostics and Therapeutics Sales and Growth Rate (2013-2018)

6 Europe Stroke Diagnostics and Therapeutics by Countries

6.1 Europe Stroke Diagnostics and Therapeutics Sales, Revenue and Market Share by Countries

6.1.1 Europe Stroke Diagnostics and Therapeutics Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Stroke Diagnostics and Therapeutics Revenue and Market Share by Countries (2013-2018)

6.2 Germany Stroke Diagnostics and Therapeutics Sales and Growth Rate (2013-2018)

6.3 UK Stroke Diagnostics and Therapeutics Sales and Growth Rate (2013-2018)

6.4 France Stroke Diagnostics and Therapeutics Sales and Growth Rate (2013-2018)

6.5 Russia Stroke Diagnostics and Therapeutics Sales and Growth Rate (2013-2018)

6.6 Italy Stroke Diagnostics and Therapeutics Sales and Growth Rate (2013-2018)

7 Asia-Pacific Stroke Diagnostics and Therapeutics by Countries

7.1 Asia-Pacific Stroke Diagnostics and Therapeutics Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Stroke Diagnostics and Therapeutics Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Stroke Diagnostics and Therapeutics Revenue and Market Share by Countries (2013-2018)

7.2 China Stroke Diagnostics and Therapeutics Sales and Growth Rate (2013-2018)

7.3 Japan Stroke Diagnostics and Therapeutics Sales and Growth Rate (2013-2018)

7.4 Korea Stroke Diagnostics and Therapeutics Sales and Growth Rate (2013-2018)

7.5 India Stroke Diagnostics and Therapeutics Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Stroke Diagnostics and Therapeutics Sales and Growth Rate (2013-2018)

8 South America Stroke Diagnostics and Therapeutics by Countries

8.1 South America Stroke Diagnostics and Therapeutics Sales, Revenue and Market Share by Countries

8.1.1 South America Stroke Diagnostics and Therapeutics Sales and Market Share by Countries (2013-2018)

8.1.2 South America Stroke Diagnostics and Therapeutics Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Stroke Diagnostics and Therapeutics Sales and Growth Rate (2013-2018)

8.3 Argentina Stroke Diagnostics and Therapeutics Sales and Growth Rate (2013-2018)

8.4 Colombia Stroke Diagnostics and Therapeutics Sales and Growth Rate (2013-2018)

9 Middle East and Africa Stroke Diagnostics and Therapeutics by Countries

9.1 Middle East and Africa Stroke Diagnostics and Therapeutics Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Stroke Diagnostics and Therapeutics Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Stroke Diagnostics and Therapeutics Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Stroke Diagnostics and Therapeutics Sales and Growth Rate (2013-2018)

9.3 UAE Stroke Diagnostics and Therapeutics Sales and Growth Rate (2013-2018)

9.4 Egypt Stroke Diagnostics and Therapeutics Sales and Growth Rate (2013-2018)

9.5 Nigeria Stroke Diagnostics and Therapeutics Sales and Growth Rate (2013-2018)

9.6 South Africa Stroke Diagnostics and Therapeutics Sales and Growth Rate (2013-2018)

10 Global Stroke Diagnostics and Therapeutics Market Segment by Type

10.1 Global Stroke Diagnostics and Therapeutics Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Stroke Diagnostics and Therapeutics Sales and Market Share by Type (2013-2018)

10.1.2 Global Stroke Diagnostics and Therapeutics Revenue and Market Share by Type (2013-2018)

10.2 Diagnostics Sales Growth and Price

10.2.1 Global Diagnostics Sales Growth (2013-2018)

10.2.2 Global Diagnostics Price (2013-2018)

10.3 Therapeutics Sales Growth and Price

10.3.1 Global Therapeutics Sales Growth (2013-2018)

10.3.2 Global Therapeutics Price (2013-2018)

11 Global Stroke Diagnostics and Therapeutics Market Segment by Application

11.1 Global Stroke Diagnostics and Therapeutics Sales Market Share by Application (2013-2018)

11.2 Ischemic Stroke Sales Growth (2013-2018)

11.3 Haemorrhagic Stroke Sales Growth (2013-2018)

12 Stroke Diagnostics and Therapeutics Market Forecast (2018-2023)

12.1 Global Stroke Diagnostics and Therapeutics Sales, Revenue and Growth Rate (2018-2023)

12.2 Stroke Diagnostics and Therapeutics Market Forecast by Regions (2018-2023)

12.2.1 North America Stroke Diagnostics and Therapeutics Market Forecast (2018-2023)

12.2.2 Europe Stroke Diagnostics and Therapeutics Market Forecast (2018-2023)

12.2.3 Asia-Pacific Stroke Diagnostics and Therapeutics Market Forecast (2018-2023)

12.2.4 South America Stroke Diagnostics and Therapeutics Market Forecast (2018-2023)

12.2.5 Middle East and Africa Stroke Diagnostics and Therapeutics Market Forecast (2018-2023)

12.3 Stroke Diagnostics and Therapeutics Market Forecast by Type (2018-2023)

12.3.1 Global Stroke Diagnostics and Therapeutics Sales Forecast by Type (2018-2023)

12.3.2 Global Stroke Diagnostics and Therapeutics Market Share Forecast by Type (2018-2023)

12.4 Stroke Diagnostics and Therapeutics Market Forecast by Application (2018-2023)

12.4.1 Global Stroke Diagnostics and Therapeutics Sales Forecast by Application (2018-2023)

12.4.2 Global Stroke Diagnostics and Therapeutics Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Stroke Diagnostics and Therapeutics Picture

Table Product Specifications of Stroke Diagnostics and Therapeutics

Figure Global Sales Market Share of Stroke Diagnostics and Therapeutics by Types in 2017

Table Stroke Diagnostics and Therapeutics Types for Major Manufacturers

Figure Diagnostics Picture

Figure Therapeutics Picture

Figure Stroke Diagnostics and Therapeutics Sales Market Share by Applications in 2017

Figure Ischemic Stroke Picture

Figure Haemorrhagic Stroke Picture

Figure United States Stroke Diagnostics and Therapeutics Revenue (Value) and Growth Rate (2013-2023)

Figure Canada Stroke Diagnostics and Therapeutics Revenue (Value) and Growth Rate (2013-2023)

Figure Mexico Stroke Diagnostics and Therapeutics Revenue (Value) and Growth Rate (2013-2023)

Figure Germany Stroke Diagnostics and Therapeutics Revenue (Value) and Growth Rate (2013-2023)

Figure France Stroke Diagnostics and Therapeutics Revenue (Value) and Growth Rate (2013-2023)

Figure UK Stroke Diagnostics and Therapeutics Revenue (Value) and Growth Rate (2013-2023)

Figure Russia Stroke Diagnostics and Therapeutics Revenue (Value) and Growth Rate (2013-2023)

Figure Italy Stroke Diagnostics and Therapeutics Revenue (Value) and Growth Rate (2013-2023)

Figure China Stroke Diagnostics and Therapeutics Revenue (Value) and Growth Rate (2013-2023)

Figure Japan Stroke Diagnostics and Therapeutics Revenue (Value) and Growth Rate (2013-2023)

Figure Korea Stroke Diagnostics and Therapeutics Revenue (Value) and Growth Rate (2013-2023)

Figure India Stroke Diagnostics and Therapeutics Revenue (Value) and Growth Rate (2013-2023)

Figure Southeast Asia Stroke Diagnostics and Therapeutics Revenue (Value) and Growth Rate (2013-2023)

Figure Brazil Stroke Diagnostics and Therapeutics Revenue (Value) and Growth Rate (2013-2023)

Figure Egypt Stroke Diagnostics and Therapeutics Revenue (Value) and Growth Rate (2013-2023)

Figure Saudi Arabia Stroke Diagnostics and Therapeutics Revenue (Value) and Growth Rate (2013-2023)

Figure South Africa Stroke Diagnostics and Therapeutics Revenue (Value) and Growth Rate (2013-2023)

Figure Nigeria Stroke Diagnostics and Therapeutics Revenue (Value) and Growth Rate (2013-2023)

Table Abbott Laboratories Basic Information, Manufacturing Base and Competitors

Table Abbott Laboratories Stroke Diagnostics and Therapeutics Type and Applications

Table Abbott Laboratories Stroke Diagnostics and Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Cordis Basic Information, Manufacturing Base and Competitors

Table Cordis Stroke Diagnostics and Therapeutics Type and Applications

Table Cordis Stroke Diagnostics and Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Boston Scientific Basic Information, Manufacturing Base and Competitors

Table Boston Scientific Stroke Diagnostics and Therapeutics Type and Applications

Table Boston Scientific Stroke Diagnostics and Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Siemens Basic Information, Manufacturing Base and Competitors

Table Siemens Stroke Diagnostics and Therapeutics Type and Applications

Table Siemens Stroke Diagnostics and Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Genentech Basic Information, Manufacturing Base and Competitors

Table Genentech Stroke Diagnostics and Therapeutics Type and Applications

Table Genentech Stroke Diagnostics and Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Koninklijke Philips Basic Information, Manufacturing Base and Competitors

Table Koninklijke Philips Stroke Diagnostics and Therapeutics Type and Applications

Table Koninklijke Philips Stroke Diagnostics and Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Medtronic Basic Information, Manufacturing Base and Competitors

Table Medtronic Stroke Diagnostics and Therapeutics Type and Applications

Table Medtronic Stroke Diagnostics and Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table GE Healthcare Basic Information, Manufacturing Base and Competitors

Table GE Healthcare Stroke Diagnostics and Therapeutics Type and Applications

Table GE Healthcare Stroke Diagnostics and Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Stryker Basic Information, Manufacturing Base and Competitors

Table Stryker Stroke Diagnostics and Therapeutics Type and Applications

Table Stryker Stroke Diagnostics and Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Merck Basic Information, Manufacturing Base and Competitors

Table Merck Stroke Diagnostics and Therapeutics Type and Applications

Table Merck Stroke Diagnostics and Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Global Stroke Diagnostics and Therapeutics Sales by Manufacturer (2016-2017)

Figure Global Stroke Diagnostics and Therapeutics Sales Market Share by Manufacturer in 2016

Figure Global Stroke Diagnostics and Therapeutics Sales Market Share by Manufacturer in 2017

Table Global Stroke Diagnostics and Therapeutics Revenue by Manufacturer (2016-2017)

Figure Global Stroke Diagnostics and Therapeutics Revenue Market Share by Manufacturer in 2016

Figure Global Stroke Diagnostics and Therapeutics Revenue Market Share by Manufacturer in 2017

Figure Top 3 Stroke Diagnostics and Therapeutics Manufacturer (Revenue) Market Share in 2017

Figure Top 6 Stroke Diagnostics and Therapeutics Manufacturer (Revenue) Market Share in 2017

Figure Global Stroke Diagnostics and Therapeutics Sales and Growth Rate (2013-2018)

Figure Global Stroke Diagnostics and Therapeutics Revenue and Growth Rate (2013-2018)

Table Global Stroke Diagnostics and Therapeutics Sales by Regions (2013-2018)

Table Global Stroke Diagnostics and Therapeutics Sales Market Share by Regions (2013-2018)

Table Global Stroke Diagnostics and Therapeutics Revenue by Regions (2013-2018)

Figure Global Stroke Diagnostics and Therapeutics Revenue Market Share by Regions in 2013

Figure Global Stroke Diagnostics and Therapeutics Revenue Market Share by Regions in 2017

Figure North America Stroke Diagnostics and Therapeutics Sales and Growth Rate (2013-2018)

Figure Europe Stroke Diagnostics and Therapeutics Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Stroke Diagnostics and Therapeutics Sales and Growth Rate (2013-2018)

Figure South America Stroke Diagnostics and Therapeutics Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Stroke Diagnostics and Therapeutics Sales and Growth Rate (2013-2018)

Figure North America Stroke Diagnostics and Therapeutics Revenue and Growth Rate (2013-2018)

Table North America Stroke Diagnostics and Therapeutics Sales by Countries (2013-2018)

Table North America Stroke Diagnostics and Therapeutics Sales Market Share by Countries (2013-2018)

Figure North America Stroke Diagnostics and Therapeutics Sales Market Share by Countries in 2013

Figure North America Stroke Diagnostics and Therapeutics Sales Market Share by Countries in 2017

Table North America Stroke Diagnostics and Therapeutics Revenue by Countries (2013-2018)

Table North America Stroke Diagnostics and Therapeutics Revenue Market Share by Countries (2013-2018)

Figure North America Stroke Diagnostics and Therapeutics Revenue Market Share by Countries in 2013

Figure North America Stroke Diagnostics and Therapeutics Revenue Market Share by Countries in 2017

Figure United States Stroke Diagnostics and Therapeutics Sales and Growth Rate (2013-2018)

Figure Canada Stroke Diagnostics and Therapeutics Sales and Growth Rate (2013-2018)

Figure Mexico Stroke Diagnostics and Therapeutics Sales and Growth Rate (2013-2018)

Figure Europe Stroke Diagnostics and Therapeutics Revenue and Growth Rate (2013-2018)

Table Europe Stroke Diagnostics and Therapeutics Sales by Countries (2013-2018)

Table Europe Stroke Diagnostics and Therapeutics Sales Market Share by Countries (2013-2018)

Table Europe Stroke Diagnostics and Therapeutics Revenue by Countries (2013-2018)

Figure Europe Stroke Diagnostics and Therapeutics Revenue Market Share by Countries in 2016

Figure Europe Stroke Diagnostics and Therapeutics Revenue Market Share by Countries in 2017

Figure Germany Stroke Diagnostics and Therapeutics Sales and Growth Rate (2013-2018)

Figure UK Stroke Diagnostics and Therapeutics Sales and Growth Rate (2013-2018)

Figure France Stroke Diagnostics and Therapeutics Sales and Growth Rate (2013-2018)

Figure Russia Stroke Diagnostics and Therapeutics Sales and Growth Rate (2013-2018)

Figure Italy Stroke Diagnostics and Therapeutics Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Stroke Diagnostics and Therapeutics Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Stroke Diagnostics and Therapeutics Sales by Countries (2013-2018)

Table Asia-Pacific Stroke Diagnostics and Therapeutics Sales Market Share by Countries (2013-2018)

Figure Asia-Pacific Stroke Diagnostics and Therapeutics Sales Market Share by Countries 2017

Table Asia-Pacific Stroke Diagnostics and Therapeutics Revenue by Countries (2013-2018)

Figure Asia-Pacific Stroke Diagnostics and Therapeutics Revenue Market Share by Countries 2017

Figure China Stroke Diagnostics and Therapeutics Sales and Growth Rate (2013-2018)

Figure Japan Stroke Diagnostics and Therapeutics Sales and Growth Rate (2013-2018)

Figure Korea Stroke Diagnostics and Therapeutics Sales and Growth Rate (2013-2018)

Figure India Stroke Diagnostics and Therapeutics Sales and Growth Rate (2013-2018)

Figure Southeast Asia Stroke Diagnostics and Therapeutics Sales and Growth Rate (2013-2018)

Figure South America Stroke Diagnostics and Therapeutics Revenue and Growth Rate (2013-2018)

Table South America Stroke Diagnostics and Therapeutics Sales by Countries (2013-2018)

Table South America Stroke Diagnostics and Therapeutics Sales Market Share by Countries (2013-2018)

Figure South America Stroke Diagnostics and Therapeutics Sales Market Share by Countries in 2017

Table South America Stroke Diagnostics and Therapeutics Revenue by Countries (2013-2018)

Table South America Stroke Diagnostics and Therapeutics Revenue Market Share by Countries (2013-2018)

Figure South America Stroke Diagnostics and Therapeutics Revenue Market Share by Countries in 2017

Figure Brazil Stroke Diagnostics and Therapeutics Sales and Growth Rate (2013-2018)

Figure Argentina Stroke Diagnostics and Therapeutics Sales and Growth Rate (2013-2018)

Figure Colombia Stroke Diagnostics and Therapeutics Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Stroke Diagnostics and Therapeutics Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Stroke Diagnostics and Therapeutics Sales by Countries (2013-2018)

Table Middle East and Africa Stroke Diagnostics and Therapeutics Sales Market Share by Countries (2013-2018)

Figure Middle East and Africa Stroke Diagnostics and Therapeutics Sales Market Share by Countries in 2017

Table Middle East and Africa Stroke Diagnostics and Therapeutics Revenue by Countries (2013-2018)

Table Middle East and Africa Stroke Diagnostics and Therapeutics Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Stroke Diagnostics and Therapeutics Revenue Market Share by Countries in 2013

Figure Middle East and Africa Stroke Diagnostics and Therapeutics Revenue Market Share by Countries in 2017

Figure Saudi Arabia Stroke Diagnostics and Therapeutics Sales and Growth Rate (2013-2018)

Figure UAE Stroke Diagnostics and Therapeutics Sales and Growth Rate (2013-2018)

Figure Egypt Stroke Diagnostics and Therapeutics Sales and Growth Rate (2013-2018)

Figure Nigeria Stroke Diagnostics and Therapeutics Sales and Growth Rate (2013-2018)

Figure South Africa Stroke Diagnostics and Therapeutics Sales and Growth Rate (2013-2018)

Table Global Stroke Diagnostics and Therapeutics Sales by Type (2013-2018)

Table Global Stroke Diagnostics and Therapeutics Sales Share by Type (2013-2018)

Table Global Stroke Diagnostics and Therapeutics Revenue by Type (2013-2018)

Table Global Stroke Diagnostics and Therapeutics Revenue Share by Type (2013-2018)

Figure Global Diagnostics Sales Growth (2013-2018)

Figure Global Diagnostics Price (2013-2018)

Figure Global Therapeutics Sales Growth (2013-2018)

Figure Global Therapeutics Price (2013-2018)

Table Global Stroke Diagnostics and Therapeutics Sales by Application (2013-2018)

Table Global Stroke Diagnostics and Therapeutics Sales Share by Application (2013-2018)

Figure Global Haemorrhagic Stroke Sales Growth (2013-2018)

Figure Global Stroke Diagnostics and Therapeutics Sales, Revenue and Growth Rate (2018-2023)

Table Global Stroke Diagnostics and Therapeutics Sales Forecast by Regions (2018-2023)

Table Global Stroke Diagnostics and Therapeutics Market Share Forecast by Regions (2018-2023)

Figure North America Sales Stroke Diagnostics and Therapeutics Market Forecast (2018-2023)

Figure Europe Sales Stroke Diagnostics and Therapeutics Market Forecast (2018-2023)

Figure Asia-Pacific Sales Stroke Diagnostics and Therapeutics Market Forecast (2018-2023)

Figure South America Sales Stroke Diagnostics and Therapeutics Market Forecast (2018-2023)

Figure Middle East and Africa Sales Stroke Diagnostics and Therapeutics Market Forecast (2018-2023)

Table Global Stroke Diagnostics and Therapeutics Sales Forecast by Type (2018-2023)

Table Global Stroke Diagnostics and Therapeutics Market Share Forecast by Type (2018-2023)

Table Global Stroke Diagnostics and Therapeutics Sales Forecast by Application (2018-2023)

Table Global Stroke Diagnostics and Therapeutics Market Share Forecast by Application (2018-2023)

Table Distributors/Traders/ Dealers List

【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[脳卒中の診断と治療の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2023）] (Global Stroke Diagnostics and Therapeutics Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023 / GIR8106237)についてメールでお問い合わせはこちら

◆関連調査資料◆

脳卒中管理の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2023）
GIR8106238 / GlobalInfoResearch / 2018年9月17日 / 本調査レポートは、脳卒中管理の世界市場について調べ、まとめました。種類別セグメントは、CTスキャン、MRI、頸動脈超音波、脳血管撮影、心電図、その他等、用途別セグメントは、虚血性脳卒中、出血性脳卒中等に区分しました。脳卒中管理の世界市場概観、メーカー動向、メーカー別脳卒中管理シェア、市場規模推移、市場規模予測、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。・脳卒中管理の市場概観・脳卒中管理のメーカー概要（事業概要、製品種類、価格、売上、市場シェア等）・脳卒中管理のメーカー別販売動向、市場シェア、市場集中度、競争動向・脳卒中管理の世界市場規模・脳卒中管理の北米市場分析（アメリカ、カナダ、メキシコ等）・脳卒中管理のアメリカ市場規模推移・脳卒中管理のカナダ市場規模推移・脳卒中管理のメキシコ市場規模推移・脳卒中管理のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Stroke is the condition that occurs when the clot is formed in the artery and the oxygen supply to the brain is cut off, brain cells get deprived of oxygen and starts to die. Stroke can be thrombotic or embolic. Thrombotic stroke occurs when a blood clot is formed in the arteries that supply blood to the brain. This report analyzed the strokes diagnostic equipment. Scope of the Report: This report focuses on the Stroke Management in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers,...

心房細動（SPAF）治療における脳卒中予防の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2023）
GIR8106239 / GlobalInfoResearch / 2018年9月14日 / 本調査レポートは、心房細動（SPAF）治療における脳卒中予防の世界市場について調べ、まとめました。種類別セグメントは、経口直接トロンビン阻害剤、経口直接因子Xa阻害剤等、用途別セグメントは、病院、診療所、外来手術センター等に区分しました。心房細動（SPAF）治療における脳卒中予防の世界市場概観、メーカー動向、メーカー別心房細動（SPAF）治療における脳卒中予防シェア、市場規模推移、市場規模予測、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。・心房細動（SPAF）治療における脳卒中予防の市場概観・心房細動（SPAF）治療における脳卒中予防のメーカー概要（事業概要、製品種類、価格、売上、市場シェア等）・心房細動（SPAF）治療における脳卒中予防のメーカー別販売動向、市場シェア、市場集中度、競争動向・心房細動（SPAF）治療における脳卒中予防の世界市場規模・心房細動（SPAF）治療における脳卒中予防の北米市場分析（アメリカ、カナダ、メキシコ等）・心房細動（SPAF）治療における脳卒中予防のアメリカ市場規模推移・心房細動（SPAF）治療における脳卒中予防のカナダ市場規模推移・心房細動（SPAF）治療における脳卒中予防のメキシコ市場規模推移・心房細動（SPAF）治療における脳卒中予防のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Atrial fibrillation (AF) now a days has become a common and serious condition affecting almost 1-2% of the total population of age group 65 years and above. Scope of the Report: This report focuses on the Stroke Prevention in Atrial Fibrillation (SPAF) Treatment in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Increase in the aging population leads to increase in the prevalence further leads to increase rick of premature death. The worldwide market for Stroke Prevention in Atrial Fibrillation (SPAF)...

アレルギー診断と治療法の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2023）
GIR8100127 / GlobalInfoResearch / 2018年10月9日 / 本調査レポートは、アレルギー診断と治療法の世界市場について調べ、まとめました。種類別セグメントは、器械、消耗品、サービス等、用途別セグメントは、診断研究所、病院、学術研究機関等に区分しました。アレルギー診断と治療法の世界市場概観、メーカー動向、メーカー別アレルギー診断と治療法シェア、市場規模推移、市場規模予測、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。・アレルギー診断と治療法の市場概観・アレルギー診断と治療法のメーカー概要（事業概要、製品種類、価格、売上、市場シェア等）・アレルギー診断と治療法のメーカー別販売動向、市場シェア、市場集中度、競争動向・アレルギー診断と治療法の世界市場規模・アレルギー診断と治療法の北米市場分析（アメリカ、カナダ、メキシコ等）・アレルギー診断と治療法のアメリカ市場規模推移・アレルギー診断と治療法のカナダ市場規模推移・アレルギー診断と治療法のメキシコ市場規模推移・アレルギー診断と治療法のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Allergen diagnostics is identifying the allergy and preventing or curing the allergy at the different stages. Allergic diagnosis is segmented based on the different types i.e. from type I to type V. Type I allergy are those which take place primarily on epithelial surfaces which are skin, lungs, gastro intestinal track. Type IV are cellular reactions which involve T lymphocytes. The granulomatous type V allergy can be regarded as a variant of type IV allergy, as it also triggers a cell-mediated immune reaction, but involves macrophages instead of T lymphocytes. Scope of the Report: This report studies the Allergy Diagnostics...

クラミジア感染症の診断と治療の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2023）
GIR8101145 / GlobalInfoResearch / 2018年9月13日 / 本調査レポートは、クラミジア感染症の診断と治療の世界市場について調べ、まとめました。種類別セグメントは、核酸増幅試験（NAAT）、直接蛍光試験、マクロライド、キノロン類、スルホンアミド、その他等、用途別セグメントは、病院、専門クリニック、診断センター治療薬、病院薬局、ドラッグストア、その他等に区分しました。クラミジア感染症の診断と治療の世界市場概観、メーカー動向、メーカー別クラミジア感染症の診断と治療シェア、市場規模推移、市場規模予測、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。・クラミジア感染症の診断と治療の市場概観・クラミジア感染症の診断と治療のメーカー概要（事業概要、製品種類、価格、売上、市場シェア等）・クラミジア感染症の診断と治療のメーカー別販売動向、市場シェア、市場集中度、競争動向・クラミジア感染症の診断と治療の世界市場規模・クラミジア感染症の診断と治療の北米市場分析（アメリカ、カナダ、メキシコ等）・クラミジア感染症の診断と治療のアメリカ市場規模推移・クラミジア感染症の診断と治療のカナダ市場規模推移・クラミジア感染症の診断と治療のメキシコ市場規模推移・クラミジア感染症の診断と治療のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...The chlamydia infection diagnostics and therapeutics market unveils high potential owing to the rapidly rising patient pool and vast untapped opportunities. Scope of the Report: This report studies the Chlamydia Infection Diagnostics and Therapeutics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Chlamydia Infection Diagnostics and Therapeutics market by product type and applications/end industries. The global Chlamydia Infection Diagnostics and Therapeutics market is valued at xx million USD in 2017 and is expected to reach xx million...

胃腸の治療と診断の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2023）
GIR8102687 / GlobalInfoResearch / 2018年9月20日 / 本調査レポートは、胃腸の治療と診断の世界市場について調べ、まとめました。種類別セグメントは、診断、治療法等、用途別セグメントは、病院薬局、小売薬局、オンライン薬局等に区分しました。胃腸の治療と診断の世界市場概観、メーカー動向、メーカー別胃腸の治療と診断シェア、市場規模推移、市場規模予測、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。・胃腸の治療と診断の市場概観・胃腸の治療と診断のメーカー概要（事業概要、製品種類、価格、売上、市場シェア等）・胃腸の治療と診断のメーカー別販売動向、市場シェア、市場集中度、競争動向・胃腸の治療と診断の世界市場規模・胃腸の治療と診断の北米市場分析（アメリカ、カナダ、メキシコ等）・胃腸の治療と診断のアメリカ市場規模推移・胃腸の治療と診断のカナダ市場規模推移・胃腸の治療と診断のメキシコ市場規模推移・胃腸の治療と診断のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Gastrointestinal disorders are related to digestive system and generally affect the colon, small & large intestine and rectum. The disorders include constipation, peptic ulcer diseases and irritable bowel syndrome. The major reason and cause of GI disorders are stress, intake of medicines such as iron pills and anti-depressants and unhealthy eating habits. Symptoms of the gastrointestinal infections include pain, bloating, diarrhea, nausea and vomiting. The major drugs that dominate the gastrointestinal diagnostics and therapeutics market are aciphex, afinitor, akynzeo, dificid and Prilosec. Scope of the Report: This report focuses on the Gastrointestinal Therapeutics and Diagnostics in global market, especially in...

急性虚血性脳卒中の診断と治療の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2023）
GIR8100032 / GlobalInfoResearch / 2018年10月22日 / 本調査レポートは、急性虚血性脳卒中の診断と治療の世界市場について調べ、まとめました。種類別セグメントは、コンピュータ断層撮影（CT）、磁気共鳴イメージング（MRI）、頸動脈超音波、脳血管造影、心電図、その他等、用途別セグメントは、組織プラスミノゲン活性化因子、抗凝固剤、抗血小板薬、抗高血圧症等に区分しました。急性虚血性脳卒中の診断と治療の世界市場概観、メーカー動向、メーカー別急性虚血性脳卒中の診断と治療シェア、市場規模推移、市場規模予測、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。・急性虚血性脳卒中の診断と治療の市場概観・急性虚血性脳卒中の診断と治療のメーカー概要（事業概要、製品種類、価格、売上、市場シェア等）・急性虚血性脳卒中の診断と治療のメーカー別販売動向、市場シェア、市場集中度、競争動向・急性虚血性脳卒中の診断と治療の世界市場規模・急性虚血性脳卒中の診断と治療の北米市場分析（アメリカ、カナダ、メキシコ等）・急性虚血性脳卒中の診断と治療のアメリカ市場規模推移・急性虚血性脳卒中の診断と治療のカナダ市場規模推移・急性虚血性脳卒中の診断と治療のメキシコ市場規模推移・急性虚血性脳卒中の診断と治療のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）... Scope of the Report: This report studies the Acute Ischemic Stroke Diagnosis and Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Acute Ischemic Stroke Diagnosis and Treatment market by product type and applications/end industries. According to a World Health Organization (WHO) estimate, around 17 million people die every year due to cardiovascular diseases. Ischemic stroke is caused by a dysfunction in the supply of blood to the brain due to emboli, thrombus or atherosclerosis occurring...

組織診断の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2023）
GIR8106554 / GlobalInfoResearch / 2018年9月19日 / 本調査レポートは、組織診断の世界市場について調べ、まとめました。種類別セグメントは、診断用消耗品、診断機器等、用途別セグメントは、病院、診断研究所、その他等に区分しました。組織診断の世界市場概観、メーカー動向、メーカー別組織診断シェア、市場規模推移、市場規模予測、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。・組織診断の市場概観・組織診断のメーカー概要（事業概要、製品種類、価格、売上、市場シェア等）・組織診断のメーカー別販売動向、市場シェア、市場集中度、競争動向・組織診断の世界市場規模・組織診断の北米市場分析（アメリカ、カナダ、メキシコ等）・組織診断のアメリカ市場規模推移・組織診断のカナダ市場規模推移・組織診断のメキシコ市場規模推移・組織診断のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Tissue diagnostic procedures are majorly used for cancer diagnosis. Some of the major tissue diagnostic tests are immunochemistry (IHC), haematoxylin and eosin (H&E), and in situ hybridization (ISH) Scope of the Report: This report studies the Tissue Diagnostics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Tissue Diagnostics market by product type and applications/end industries. Growing prevalence of cancer coupled with growing demand for personalized medicine are anticipated to propel the growth of the tissue diagnostic market...

結核（TB）診断の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2023）
GIR8106655 / GlobalInfoResearch / 2018年9月18日 / 本調査レポートは、結核（TB）診断の世界市場について調べ、まとめました。種類別セグメントは、スミア顕微鏡、分子テスト、マントーツベルクリン試験、培養、薬剤感受性試験、その他等、用途別セグメントは、診断研究所、病院等に区分しました。結核（TB）診断の世界市場概観、メーカー動向、メーカー別結核（TB）診断シェア、市場規模推移、市場規模予測、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。・結核（TB）診断の市場概観・結核（TB）診断のメーカー概要（事業概要、製品種類、価格、売上、市場シェア等）・結核（TB）診断のメーカー別販売動向、市場シェア、市場集中度、競争動向・結核（TB）診断の世界市場規模・結核（TB）診断の北米市場分析（アメリカ、カナダ、メキシコ等）・結核（TB）診断のアメリカ市場規模推移・結核（TB）診断のカナダ市場規模推移・結核（TB）診断のメキシコ市場規模推移・結核（TB）診断のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those infected. The classic symptoms of active TB are a chronic cough with blood-containing sputum, fever, night sweats, and weight loss. Scope of the Report: This report studies the Tuberculosis (TB) Diagnostics market status and outlook of Global and major...

敗血症診断の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2023）
GIR8105833 / GlobalInfoResearch / 2018年9月28日 / 本調査レポートは、敗血症診断の世界市場について調べ、まとめました。種類別セグメントは、微生物学、分子診断、イムノアッセイ、フローサイトメトリー、マイクロフルイディクス、その他等、用途別セグメントは、病院、病理検査センター等に区分しました。敗血症診断の世界市場概観、メーカー動向、メーカー別敗血症診断シェア、市場規模推移、市場規模予測、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。・敗血症診断の市場概観・敗血症診断のメーカー概要（事業概要、製品種類、価格、売上、市場シェア等）・敗血症診断のメーカー別販売動向、市場シェア、市場集中度、競争動向・敗血症診断の世界市場規模・敗血症診断の北米市場分析（アメリカ、カナダ、メキシコ等）・敗血症診断のアメリカ市場規模推移・敗血症診断のカナダ市場規模推移・敗血症診断のメキシコ市場規模推移・敗血症診断のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Sepsis is a three-staged syndrome; it starts with systemic infections leading to severe sepsis and ultimately causing sepsis shock, which is regarded as a medical emergency. Population with weak immune system, which include children, older adults, and people with chronic diseases such as cancer, AIDS, diabetes, are prone to sepsis. Sepsis occurs mainly due to bacterial, viral, and fungal infections. Gram-negative bacilli such as E. coli, P. aeruginosa, E. corrodens, and Haemophilus influenzae (which occurs mainly in neonates) are the main agents that cause infection, leading to sepsis. Other bacteria which causes sepsis are S. aureus, Streptococcus species, Enterococcus species,...

全身性乾癬治療薬の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2023）
GIR8106396 / GlobalInfoResearch / 2018年9月26日 / 本調査レポートは、全身性乾癬治療薬の世界市場について調べ、まとめました。種類別セグメントは、生物製剤、小分子等、用途別セグメントは、軽度の乾癬、中等度の乾癬、重症乾癬等に区分しました。全身性乾癬治療薬の世界市場概観、メーカー動向、メーカー別全身性乾癬治療薬シェア、市場規模推移、市場規模予測、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。・全身性乾癬治療薬の市場概観・全身性乾癬治療薬のメーカー概要（事業概要、製品種類、価格、売上、市場シェア等）・全身性乾癬治療薬のメーカー別販売動向、市場シェア、市場集中度、競争動向・全身性乾癬治療薬の世界市場規模・全身性乾癬治療薬の北米市場分析（アメリカ、カナダ、メキシコ等）・全身性乾癬治療薬のアメリカ市場規模推移・全身性乾癬治療薬のカナダ市場規模推移・全身性乾癬治療薬のメキシコ市場規模推移・全身性乾癬治療薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Psoriasis is an autoimmune skin disease that causes scaling, skin redness and irritation. Psoriasis causes red, scaly patches that are generally found on the elbows, fingernails, scalp, palms, knees, face, feet and inside the mouth. Factors that can trigger psoriasis include infections, heavy alcohol consumption, cold weather, certain medications, smoking, stress and injury to the skin such as bug bite, cut and sever sunburn. The signs and symptoms of psoriasis vary from person to person which includes dry, cracked skin that may bleed, red patches of skin covered with silvery scales, small scaling spots, itching, burning, swollen and stiff joints....

◆H&Iグローバルリサーチ株式会社のお客様（例）◆